PARP inhibitors, used to treat tumors whose cells have problems repairing damaged DNA, become ineffective when cancer cells lose the DNA-modifying enzyme TET2.
Full story at National Cancer Institute
PARP inhibitors, used to treat tumors whose cells have problems repairing damaged DNA, become ineffective when cancer cells lose the DNA-modifying enzyme TET2.
Full story at National Cancer Institute
The Encyclopedia of DNA Elements is a growing trove of information that is vital for interpreting the genetic code.
Full story at Cold Spring Harbor Laboratory
A new animal model will help researchers investigate why some pancreatic cancers are more aggressive than others and what causes them to progress.
Full story at Cold Spring Harbor Laboratory
Ultra-black fish skin absorbs more than 99 percent of the light that hits it, using an efficient strategy that could be applied to optical and camouflage technology.
Full story at Smithsonian
Using DNA sequencing instead of microscopy dramatically reduces the cost of mapping brain-wide connections.
Full story at Cold Spring Harbor Laboratory
Preclinical findings suggest that interfering with the way pancreatic cancer cells store cholesterol could be a way to treat the disease.
Full story at Cold Spring Harbor Laboratory
Chemoimmunotherapy can lead to long-lasting remissions of HIV-associated primary central nervous system lymphoma, without impairing cognitive function.
Full story at National Cancer Institute
High levels of the sticky, pathogen-trapping webs produced by certain immune cells were associated with the most severe cases of COVID-19 in a clinical study.
Full story at Cold Spring Harbor Laboratory
A single chandelier cell reaches out to connect and communicate with more than 100 other neurons.
Full story at Cold Spring Harbor Laboratory